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ABSTRACT
Purpose: Evaluate the bone tissue recovery following transplantation of ovine mesenchymal stem cells (MSC) from bone marrow
and human immature dental-pulp stem cells (hIDPSC) in ovine model of induced osteonecrosis of femoral head (ONFH).
Methods: Eight sheep were divided in three experimental groups. First group was composed by four animals with ONFH induced by
ethanol through central decompression (CD), for control group without any treatment. The second and third group were compose by
two animals, six weeks after ONFH induction received transplantation of heterologous ovine MSC (CD + oMSC), and hIDPSC
(CD + hIDPSC), respectively. In both experiments the cells were transplanted without application of any type of immunosupression
protocol. Results: Our data indicate that both cell types used in experiments were able to proliferate within injured site providing
bone tissue recovery. The histological results obtained from CD+hIDPSC suggested that the bone regeneration in such animals was
better than that observed in CD animals. Conclusion: Mesenchymal stem cell transplant in induced ovine osteonecrosis of femoral head
by central decompression technique is safe, and apparently favors bone regeneration of damaged tissues.
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RESUMO
Objetivo: Verificar os efeitos das células-tronco mesenquimais da medula óssea de ovinos e da polpa dentária imatura humana em
ovinos com osteonecrose induzida, da cabeça do fêmur. Métodos: Oito ovelhas foram distribuídas em três grupos experimentais. O
primeiro grupo foi composto por quatro animais com osteonecrose da cabeça do fêmur induzida por etanol através da descompressão
central, que não receberam nenhum tratamento. O segundo e o terceiro grupo, cada um composto por dois animais, receberam transplante
heterólogo de células tronco mesenquimais de ovinos e polpa dentária imatura humana seis semanas após a indução da osteonecrose da
cabeça do fêmur, respectivamente. Em ambos os grupos experimentais as células foram transplantadas sem o uso de drogas
imunossupressoras. Resultados: Os achados demonstram que as células-tronco mesenquimais injetadas na cabeça do fêmur se encontravam
viáveis após o transplante no novo sítio e proliferaram em pouco tempo. Os dados histológicos sugerem que a regeneração óssea nos
animais transplantados com polpa dentária imatura humana foi mais rápida do que nos animais submetidos somente a descompressão
central. Conclusão: O transplante de células tronco mesenquimais na osteonecrose da cabeça do fêmur induzida em ovinos através da
técnica de descompressão central é um procedimento seguro, e aparentemente favorece a regeneração óssea de tecidos lesados.
Descritores: Articulação do Quadril. Células-Tronco. Cabeça do Fêmur. Ovinos.
1Research performed at Post-graduate Program of Anatomy in Domestic and Wild Animals, Department of Veterinary Surgery, Faculty of Veterinary
Medicine and Animal Science, Sao Paulo University (USP), Brazil. There were a collaborative work among Butantan Institute and CELLTROVET, a
Brazilian company of stem cell supply and UNIFEOB, where made preclinical trials with ovine.
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Introduction
Osteonecrosis of the femoral head (ONFH) is a
progressive degenerative disease that leads to the total collapse
of the femoral head and that requires an excisional arthroplasty
for the replacement of the coxofemural articulation. Because
preservation of the articulation is a desired goal, conservative
procedures are used for treating the initial stages of ONFH1.
ONFH is a multifactorial disease for which the pathogeny is still
unknown. Some of the known risk factors of developing ONFH
are abusive consumption of alcohol and prolonged use of steroids
in patients with immune-mediated disease2.
Among the treatment choices to preserve articulation
are central decompression, central decompression associated
to vascularized and non-vascularized bone graft, autologous
transplant of bone-marrow stem cells, and extracorporeal
shockwave treatment2-5.
Several models have been used to create the human
disease, with the aim of testing therapeutic approaches able to
preserve the coxofemural articulation. Most of these models
have been based on the vascular suppression theory in which the
disease may be induced either surgically or through overdoses of
steroid drugs6.
However, ovines are excellent animal model for
translational medicine because the body scores close to humans
and as production animal, a suitable specie for housekeeping and
management7-10.
Treatment choices suggested so far show viable results
only when applied at the subclinical stages of the disease. As
for the experimental models, these lead to the total collapse of the
femoral head, leaving no options other than its replacement2-6,11.
The ovine model suggested by Manggold12 shows
characteristics similar to those found at the early stages of
osteonecrosis in human, in which the articular cartilage is kept
intact, the internal trabecular structure is preserved, and
macrocirculation is maintained. The anatomic dimensions of
the model are similar to those of humans, making it a useful
experimental model for developing therapies for ONFH.
Mesenchymal stem cells (MSC) can be easily isolated
from bone marrow and expanded in vitro. Currently these cells
are the best studied, when compare with stem cells from other
sources from adult tissues. Their therapeutic potential has been
demonstrated previously in multiple studies13.
The dental pulp of deciduous teeth is another, and recent,
alternative for obtaining MSC. Recent works suggest that these
cells carry a great potential to be used in tissue reconstruction and
especially in orthopedics once they are of easy access (isolation
from dental pulp), efficient extraction, great capacity to
differentiate, and good affinity with biomaterials14.
Studies done in patients with ONFH have shown that
the level of activity and the number of mesenchymal cells inside
the stromal and hematopoietic compartments of the bone marrow
are depressed in these patients15. These findings have indicated
that mesenchymal bone cells can be used on necrotic injuries of
the femoral head16.
Although cell therapy for ONFH in humans has produced
satisfactory results17, in transplanted patients who are evaluated
years later different levels of transplant effectiveness are observed.
It is still not known how many cells survive after the transplant or
how they may in fact contribute to the regenerative process18.
Among the different techniques that have been proposed
to track the fate of implanted cells in vivo, methods involving
transduction of detectable genetic markers, such as those encoding
for ß-galactosyltransferase (LacZ) and green fluorescent protein
gene (GFP), are the only ones that allow stable and reliable
long-term tracking of transplanted cells19.
In the present study we applied cellular therapy using
MSC from ovine bone marrow and human immature dental-pulp
stem cells (hIDPSC) in ovines with ONFH induced by intra-bone
injections of ethanol. We used light microscopy to evaluate the
response obtained to the applied central decompression technique
and tracked the ovine bone-marrow stem cell through the LacZ
reporter gene.
Methods
Experimental design
This study was approved by the bioethics committee of
the Faculty of Veterinary Medicine and Animal Science, Sao Paulo
University. Eight clinically healthy sheep weighing on average
35 kg and averaging one year of age were used in this study.
The animals were divided in three experimental groups.
First group was composed by four animals with ONFH induced by
ethanol through central decompression (CD), which did not receive
any treatment. The second group e third group, each was compose
by two animals, six weeks after ONFH induction received
transplantation of heterologous ovine MSC (CD+MSC), and
hIDPSC (CD+hIDPSC), respectively. All the animals of second
and third group were euthanized 10 weeks after induction of injury
for evaluation. While the animals from CD group these, two were
euthanatized 6 and 10 weeks after induction of injury to confirm
the success in reproducing the disease in the animal model. The
femoral head of the right limb (Health limb) of each animal was
used as control for the treatment done in the left limb of that animal
(ONFH Induced Limb).
Anesthesia and post-surgical procedures
After 24 hours of food fasting and 12 of not drinking
water, animals were pre-medicated with midazolam maleate
(0.6mg/kg) and meperidine hydrochloride (2mg/kg) intravenously
(IV). Anesthesia was induced by propophol (3mg/kg) associated
to fentanyl hydrochloride (2.5µg/kg) and maintained with
isoflurorane. Post-surgical analgesia was provided with 1 mg/kg
of flunixin meglumine and 25mg/kg of sodium dipyrone IV and
maintained with 2mg/kg of tramadol twice a day until animals were
euthanized. Antibacterial prophylaxis was obtained with penicillin
40000 UI/kg for 10 days.
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Culturing and isolating ovine bone-marrow MSC and
pulp hIDPSC
The 15 and 30 ml of bone marrow were collect of the iliac
crest using 5 ml syringes and a 14G bone marrow biopsy needle
(Biomedical®). The aspirate bone marrow of the ovine was filtrated
in a 100 µm mesh and diluted in PBS at 1:3. Next, the solution
was homogenized and added in to ficoll (Ficoll, Histopaque®). The
solution was centrifuged at 2000 RPM for 30 min at 20°C. The
resulting pellet was resuspended in PBS and centrifuged at 1000
RPM. The procedure was repeated three times. The pellet was then
resuspended in alpha minimum essential medium (alpha-MEM)
and plated in 25 cm2 flasks at initial density of 2.0 x 105/cm2. The
medium was supplemented with 15% fetal bovine serum (Invitrogen
Corporation) and 1% total solution of antibiotics (100 U/ml of
penicillin and 100µg/ml of streptomycin). Cells were incubated
in a Thermo Electron Corporation incubator (Forma Series ll
Water Jacketed CO2 Incubator HEPA Class 100) under culturing
conditions of 37°C, relative humidity of approximately 100%, and
5% CO2. After 5 days, no adherent cells derived BM were removed,
and the medium was replaced. At 70% confluence, cells were
harvested with 0.25% triple (Sigma, St. Louis, Mo., USA GIBCO)
for 5 minutes at 37°C and were replaced in 25- cm2 and 75 cm
flasks (Corning, New York, N.Y., USA). Images of incubated
cells were visualized in an inverted microscopy (NIKON
Eclipse-TS 100), with lenses of 4x, 10x, 20x, and 40x and kept
with a capture system (MTC Digital Color Camera).
The hIDPSC have been isolated and extensively
characterized20-24. They were cultured before transplantation
following protocol described in Kerkis et al.20.
Core decompression
To take the radiologic images we used the ventro-dorsal
projection with a Konex 30x40, film AGFA® frame. The apparatus
used was Emic® with Toshiba ampoule, 500 mA and 150 Kv. The
technique applied was 300 mA, 80 Kv at 0.08s. For the central
decompression technique we accessed the greater trochanter
through an incision in the skin with a scalpel 14 and divulsion of
the subcutaneous tissue. The superficial gluteus muscle suffered
an incision in the direction of its muscle fibers, as well as the
femoral biceps muscle, which was retracted with the help of a
Weitlaner self-retaining retractor.
After confirmation of the visualization of the greater
trochanter, a Kirschnner thread was introduced at 1 mm from the
greater trochanter to the center of the femoral head. For the greater
trochanter to be correctly aligned with the femoral head of the
animal it was necessary that a helper stretched and twisted the
animal’s member medially so the thread could be easily introduced
and reach the center of the femoral head. Once the right
radiographic position for the thread was confirmed, the 3.5 mm
cannula drill was introduced up to the femoral head, the thread was
removed, and a new radiographic image was taken to determine
the correct position of the drill in the center of the femoral head,
and 10ml of absolute ethanol were administrated. When the
procedure was over, the drill was removed, the created hole was
filled with bone wax (Johnson & Johnson), the muscles were
brought together using a simple continuous Vycril® 2-0 suture, and
the skin was brought together using a simple interrupted Nylon
2-0 suture. This procedure was done both for inducing the injury
and for the cellular therapy with bone-marrow MSC of the ovines
and hIDPSC (Figure 1).
Viral transduction of ovine bone-marrow stem cells
Exogenous genes were transfected to the ovine
bone-marrow MSC through the pLNPoZ retroviral vector created
from the MoMLV (Moloney Murine Leukemia Virus)
retrovirus. The retroviral vector used has the bacterial LacZ gene
under control of the UTR region of the poliovirus, which is the
viral promotor LTR (L) of the retrovirus that regulates the gene
expression of the neomycin phosphotransferase gene (N).
Infections of the bone marrow were done according to a 5-day
protocol with 24-hour intervals between each step of the process,
as described below.
On the first day, the clones of the amphotropic packaging
cells PT67/LNPoZ, NIH3T3 cells, and the oBMSC of the second
or third passages were seeded in tissue culture plates of 60 mm
diameter and density of 1 x 106 for the virus-producing cells and
5 x 105 for stem cells, in 4 ml of alpha-MEM. On the second day,
the culture medium was aspirated and replaced. On the third day,
the viral infection was performed. The supernatant of culture of
clones containing the PT67 virus-producing cells was carefully
homogenized, collected, and centrifuged at 10000 RPM per 1 min
at room temperature. The culture medium of the stem cells was
once again replaced, this time by a medium containing 8 µg/ml of
Polybrene. We used 1 ml of viral suspension to infect each plate
containing stem cells. On the fourth day, the culture medium was
aspirated and replaced by a new one. NIH3T3 cells were used as
positive control for the infection.
 
FIGURE 1 – Central decompression technique of the femoral head with
injections of absolute ethanol. A. Passage of the 1 mm Kirschnner from
the greater trochanter to the center of the femoral head. B. Passage of the
3.5 mm cannula drill through the great trochanter to the center of the femoral
head. C. Radiographic image of the correct position of the cannula drill.
D. Injection of absolute ethanol into the center of the femoral head.
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Expression analysis of the exogenous genes (LacZ) in
mesenchymal stem cells previously transduced
We seeded 1 x 106 cells in 60 mm plates and incubated
them with X-Gal solution (X-gal 1 mg/ml, K4Fe(CN)6 5 mM,
K3Fe(CN)6 5 mM e MgCl2 1 mM) 24 hours later to check the
expression of the ß-Gal in the ovine bone-marrow stem cells
transduced with the pLNPoZ vector. The incubation protocol with
X-Gal is described as follows: the medium culture was removed
and 0.5% glutaraldehyde solution was added over cells for 15
minutes at room temperature for fixation. The solution was then
removed and the cells washed 3 times with PBS every 5 minutes.
The X-Gal solution was added to the cells and then incubated
at 37°C for 1 to 6 hours. Stained cells were observed with
phase-contrast microscopy. The same protocol was used for
observation of ß-Gal expression in the femoral head from animals
after euthanasia. The result of procedures for introduce LacZ in
oMSC renamed these cells as LacZ-oMSC.
Preparation of oBMSCs and hIDPSCs to be transplanted
The cell cultures were trypsinized and centrifuged at 21°C
at 1000 rpm for 7 min. Pelleted cells were resuspended with PBS
and centrifuged under the same conditions. PBS washing was done
twice to remove any remaining Fetal Bovine Serum (FBS). After
cell counting, 1x106 LacZ-oMSCs and 1x106 hIDPSCs were
resuspended in 500 - 1000µl of saline solution and inoculated in
the animals.
Evaluation by light microscopy
Animals were euthanized with overdoses of sodium
thiopental 2.5%; the femoral heads were then collected and
immersed for 48 hours in formalin 10%. Specimens of the left and
right femoral heads of control and test animals were evaluated.
The femoral head was sectioned at the femoral column in 4 slices
parallel to the center of the femoral head. The material was
submitted to decalcification with formic acid 10%, inserted in
paraffin, and stained with hematoxylin and eosin.
Results
In all animals submitted to the CD technique, regardless
of receiving stem cell therapy, it was possible to observe
hemorrhagic injuries in the region where the drill was applied
and a clearer circular area at the femoral head was observed,
characterizing the collapsing of the bone usually found on the
femoral heads of humans with ONFH. The same was not
macroscopically observed in a region of bone necrosis in the
femoral heads of controls (Figure 2).
FIGURE 2 – Macroscopic aspects of femoral head and column of ovine
submitted to osteonecrosis of the femoral head and stem cell therapy.
A. Image of the femoral head of a sheep submitted to induction of
osteonecrosis of the femoral head (ONFH). B. The arrows delineate the
area of bone collapse visible in (A). C. The arrows point to the passage of
the cannula drill, from the great trochanter to the center of the femoral
head. D. Femoral head of the contralateral member of the same animal.
The oMSCs cultivated in this experiment were effectively
transduced with the LacZ reporter gene expressing the ß-Gal
(Figure 3).
FIGURE 3 - Representative figures of expression of ß-Gal (blue) by LacZ
gene reporter observed in the bone-marrow stem cells of ovines (A,B).
Scale bar: A, B = 100µm.
After transplant can be identification of the LacZ-oMSCs
cells in the center of the femoral head proliferated by expression
gene ß-Gal (blue), performed X-gal stained. This result indicates
the success of the transplant technique and as well engraftment of
MSC cells. We used samples of the femoral head of test samples
and of controls to search for the presence of the Lac Z reporter
gene (Figure 4).
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Samples of femoral head (CD- group) were processed
according to the same protocol used for the expression analysis
of MSC in vitro.
FIGURE 4 – Representative figure of expression of the reporter gene
LacZ is evidenced by ß-Gal staining in the femoral head of ovines.
A. Ovine femoral head control (Health limb). B. Experimental expressing
LacZ.
Slices were prepared for histological analysis from
the CD group, from the CD+hIDPSC group and from the control
group (Health Limb). The trabecular portion of the femoral head
of the CD group, which did not receive cell transplantation,
(left – experimental) was filled after 6 weeks with live bone
marrow and rich in mesenchymal cells and osteoblasts,
demonstrating the process of bone tissue repairing usually
occurring in young animals, which suffer injury in this region,
apparent decrease of the space composed by compact bone was
observed. Furthermore, on higher magnification the presence of
bone marrow precursor cells was visualized, suggesting their
further differentiation and new bone tissue formation. These
findings indicate that the bone was in its initial process of bone
tissue regeneration. Slices from CD+oBMSC were not obtained
due to failures in processing the material for histological analysis.
Apparently, the trabecular bone was better organized in the
CD+hIDPSC group than in the CD group and was similar to that
found in controls. Evaluation of the femoral head of the
CD+hIDPSC group showed the remnants of the bone marrow in
the live trabecular bone proximal to the cartilage, although in smaller
amounts than found in the CD group. Our data suggest that use
of hIDPSC make contribution to better regeneration process as
compared with CD group. Since, slices from CD+oBMSC were
not obtained due to failures in processing the material for
histological analysis impeding such comparison (Figure 5).
FIGURE 5 – Photomicrographies of the femoral head of ovines
submitted to induction of osteonecrosis of the femoral head with ethanol
and heterologous transplant of of mesenchymal bone-marrow cells from
different sources. A. Arrow indicates presence of live bone marrow in the
bone trabeculae. B. Zoom-in of the region shown in (A); black arrow points
to cell of mesenchymal origin, red arrow to osteoblasts. C. Red arrow
delineates region of the compact lamellar bone and black arrow the
trabecular bone region in the control animal. D. Trabecular bone, arrow
points to traces of live bone marrow. Magnifications of 4x (A, C, and D)
and of 40X (B).
Discussion
Sheep were used in this experiment because of their
similar hip anatomy to humans, and because of their size which
allows perform surgical procedures used in humans25. These
features make the sheep a good model for studies in orthopedic
surgery.
Six weeks after ethanol injection in femoral head of the
ovines through the core decompression technique Manggold et al.8
found most severely damaged areas in the femoral head, and bone
regeneration occurred in twelve weeks after induction. Therefore,
we chose perform the transplantation of stem cells six weeks after
ONFH induction, and evaluate the cell therapy result 10 weeks
after induction.
The main objective of the treatment in ONFH is to
preserve the hip joint. Stem cell therapy in ONFH could be a
helpful tool in this disease, avoiding the progression of injury,
and representing a possible cure. According Caplan26, adult
stem cells provide replacement and repair descendants for normal
turnover or injured tissues. These cells have been isolated and
expanded in culture, and their use for therapeutic strategies requires
Our preliminary histological studies showed a good
bone tissue recovery in animals, which received hIDPSC.
However, we cannot confirm, that benefits observed in CD-hIDPSC
group are, in fact, exclusively due to hIDPSC transplantation.
Feitosa MLT et al
421  -  Acta Cirúrgica Brasileira - Vol. 25 (5) 2010
technologies not yet perfected. This article provides more
information about mesenchymal stem cell therapy, and behavior
of transplanted cells in site of injury.
Stem cells from human dental pulp are the new promise
of cell therapy. These cells were isolated, cultured and extensively
characterized by Kerkis et al.20. However, few clinical trials
have been performed with these cells in the field of cell therapy
and tissue engineering. In this study, hIDPSC were applied in an
animal model, providing more information about safe and the
efficacy of these cells.
Although some relevant clinical data on cellular therapy
for ONFH exist8,16,17,27, it remains unknown how many of these cells
actually participate in the bone reparation and engraftment process
and how many survive and proliferate in the center of the femoral
head, after the transplant. This observation has also been made
by others18. For stem cell therapy we choose to used oMSC and
LacZ-oMSC  due to small number of transduced cells obtained
after the procedures for viral transduction. Despite the small amount
of LacZ-oMSC injected, the X-Gal staining was positive in all gross
slices of femoral head in CD+oMSC group. We cannot say
precisely how many cells proliferated but the fact that we were
able to macroscopically detect the ß-galactosidase expression four
weeks after the transplant of LacZ-oMSCs, indicates that great cell
proliferation had occurred.
The methods used to tracking modified MSC in a bone
defect did have obtained limited success, mainly because the label
was not compatible with the specifics procedures used for bone
histology19.In this study the bone samples used for evaluate
CD+oMSC  group were lost in procedures cause by bone
histology preparation. However, the macroscopic findings after
X-Gal staining gave us positive results, confirming the success of
transplant.
The studies performed by Hernigou et al.15 done in
patients with ONFH have shown that the level of activity and
the number of mesenchymal cells inside the stromal and
hematopoietic compartments of the bone marrow are depressed
in these patients. Gangji et al.16,17,27 used in their experiments
eighteen patients with ONFH, and treated then with core
decompression alone, and core decompression associated with
bone marrow mononuclear cells. A follow up of five years showed
that only one of ten patients, in the experimental group, have need
of a total hip replacement after the therapy, and four of eight
patients in the control group underwent prosthetic surgery. These
data leave us to believe that mesenchymal stem cell therapy is a
promising treatment on ONFH. Thus it seems appropriate that a
treatment performed with purified mesenchymal stem cells and
would be more effective than using a pool of mononuclear cells. In
our study we used expanded in culture mesenchymal stem cells for
two sources, instead of simple pool fresh extract from patient.
A case report done by Kim et al.27 showed a 31 years
old patient with bilateral ONFH that was submitted a core
decompression with allograft implant in left femoral head, while
the right side was treated by injection of autologous cultured
osteoblasts for four weeks after the core decompression. The
author concludes that despite using only a patient, cultured
osteoblasts appear to be effective for treatment. Bone is a living
organ. Mesenchymal stem cells can differentiate into different cell
types, such as bone, cartilage, fat and vessels. For this reason, we
believe that a mesenchymal stem cell therapy is more appropriate
than the use of cultured osteoblasts, because these cells can give
rise to all cell types found in bone tissue.
In Brazil, Daltron et al.28 performed the treatment of
ONFH with mononuclear bone marrow cells in sickle cell disease
in eight patients. After eigth months, seven of the eight patients
reported improvement from symptoms. The authors consider that
the interpretation or these early results is limited due to the small
sample and to the short duration of follow-up. We consider the
same. The small number of animals in our research is due to the
high cost of animals and their maintenance. A follow-up in ovine
model of ONFH is not possible because the injury induced
presents spontaneous resolution. Our data are in accordance to
previous studies, which successfully applied the central
decompression technique associated with autologous bone
marrow cells in humans17,28. We also showed that the procedure
performed in this study is safe and does not lead to bone fractures
or to the appearance of tumors, and that the cells used for treatment
are still alive weeks after the procedure.
Conclusions
Our findings show that the MSC injected in the femoral
head were able to engraftment in the bone tissue. In contrast the
histological data of human immature dental-pulp stem cells
transplanted suggested that the bone regeneration in animals
was faster than that observed in animals submitted to central
decompression alone. Furthermore Our preliminary data
demonstrated that ovine model of osteonecrosis of femoral head
can be successfully used in comparative studies of animal and
human stem cell transplantation aiming at reconstruction of  bone
tissue injury.
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